Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
Product Launch
|
Mid-range Performer
951.9500
-4.30
(
-0.45
%)
NSE
Mar 04, 2026
15:08 PM
30.98% Gain from 52W Low
Volume:
2.9M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
21 Jun 2023
Product Launch
951.95
-0.45%
NATCO PHARMA
Buy:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 765
Target
Geojit BNP Paribas
Natco Pharma Ltd. is trading above all available SMAs
More from Natco Pharma Ltd.
Recommended
Market trades lower, Adani Ports' cargo handled jumps 16% YoY in February
Trendlyne Marketwatch |
04 Mar 2026, 03:03PM
Bad timing: New listings sink on debut amid market turmoil
|
02 Mar 2026, 05:29PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020